ConductScience.org, home

Paper35525908

Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease.

Zhu L and 3 others. Stem Cell Rev Rep, 2022. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease. Papers, record 35525908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35525908

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease.
PubMed
Journal
Stem Cell Rev Rep
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
2.4
iCite
Revised in PubMed
2026-10-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhu LLiyuan
2Liu KKui
3Feng QQi
4Liao YYingnanhttps://orcid.org/0000-0001-5351-4783

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
OrganoidsMajor topic
Induced Pluripotent Stem CellsMajor topic
Humans
Organogenesis
Regenerative Medicine
Technology

References91

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134208210Tunable Human Myocardium Derived Decellularized Extracellular Matrix for 3D Bioprinting and Cardiac Tissue Engineering.Gels2021https://conductscience.org/library/papers/34208210PubMed
228167635Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair.Circulation2017https://conductscience.org/library/papers/28167635PubMed
328931002Enhanced proofreading governs CRISPR-Cas9 targeting accuracy.Nature2017https://conductscience.org/library/papers/28931002PubMed
427765793A Precision Medicine Approach to the Rescue of Function on Malignant Calmodulinopathic Long-QT Syndrome.Circ Res2017https://conductscience.org/library/papers/27765793PubMed
529233823Large Cardiac Muscle Patches Engineered From Human Induced-Pluripotent Stem Cell-Derived Cardiac Cells Improve Recovery From Myocardial Infarction in Swine.Circulation2018https://conductscience.org/library/papers/29233823PubMed
627642787iPSC-derived cardiomyocytes reveal abnormal TGF-β signalling in left ventricular non-compaction cardiomyopathy.Nat Cell Biol2016https://conductscience.org/library/papers/27642787PubMed
731385592Engineered Cardiac Tissues Generated in the Biowire II: A Platform for Human-Based Drug Discovery.Toxicol Sci2019https://conductscience.org/library/papers/31385592PubMed
830623132Novel Adult-Onset Systolic Cardiomyopathy Due to MYH7 E848G Mutation in Patient-Derived Induced Pluripotent Stem Cells.JACC Basic Transl Sci2018https://conductscience.org/library/papers/30623132PubMed
99521325Genetic basis and molecular mechanism for idiopathic ventricular fibrillation.Nature1998https://conductscience.org/library/papers/9521325PubMed
1026735016High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.Nature2016https://conductscience.org/library/papers/26735016PubMed
1129525646Gene Editing and Gene-Based Therapeutics for Cardiomyopathies.Heart Fail Clin2018https://conductscience.org/library/papers/29525646PubMed
1228174241Development of a human cardiac organoid injury model reveals innate regenerative potential.Development2017https://conductscience.org/library/papers/28174241PubMed
1317971785Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.Nat Rev Drug Discov2007https://conductscience.org/library/papers/17971785PubMed
1428765558Cardiac spheroids as promising in vitro models to study the human heart microenvironment.Sci Rep2017https://conductscience.org/library/papers/28765558PubMed
1532464269Decellularized tissues as platforms for in vitro modeling of healthy and diseased tissues.Acta Biomater2020https://conductscience.org/library/papers/32464269PubMed
1626911908Organoids as an in vitro model of human development and disease.Nat Cell Biol2016https://conductscience.org/library/papers/26911908PubMed
1716339494Engineering myocardial tissue.Circ Res2005https://conductscience.org/library/papers/16339494PubMed
1826433566Development of a three-dimensional pre-vascularized scaffold-free contractile cardiac patch for treating heart disease.J Heart Lung Transplant2016https://conductscience.org/library/papers/26433566PubMed
1926503464Bioengineering Human Myocardium on Native Extracellular Matrix.Circ Res2016https://conductscience.org/library/papers/26503464PubMed
2030710266Measurement of Contractility and Calcium Release in Cardiac Spheroids.Methods Mol Biol2019https://conductscience.org/library/papers/30710266PubMed

See all 91 referencesDownload CSV of references

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
42882452Emerging Technologies in Cardiovascular Disease Modeling: Bridging Basic Science and Clinical Translation.Cells2026https://conductscience.org/library/papers/42882452PubMed
42637927The cardiac protective human circular RNA circKLHL20_009 sponges miR-31-5p to ameliorate myocardial hypertrophy and fibrosis through suppressing β-catenin signaling.Acta Pharmacol Sin2026https://conductscience.org/library/papers/42637927PubMed
42579795From aging biology to cardiac biotechnology: emerging platforms for modeling cardiac aging.JCI Insight2026https://conductscience.org/library/papers/42579795PubMed
42306928Advances in Biomaterial-Based Cardiac Organoids Engineering for Modeling Development and Congenital Heart Defects.ACS Appl Bio Mater2026https://conductscience.org/library/papers/42306928PubMed
42277205S1UTRSP5, a short restructured RNA from SLIT1 3'UTR, mitigates mouse cardiac remodeling via enhancing SlRT1 activity.Acta Pharmacol Sin2026https://conductscience.org/library/papers/42277205PubMed
41677066Patient-Derived 3D Bioprinted Cardiac Organoid Constructs Reveal Key Pathological Features of Duchenne Muscular Dystrophy.Adv Healthc Mater2026https://conductscience.org/library/papers/41677066PubMed
41618376Advanced imaging strategies in cardiac organoids: bridging the gap between structural complexity and functional analysis.Cardiovasc Diabetol2026https://conductscience.org/library/papers/41618376PubMed
41556511Unraveling the Genetic Mysteries of Müllerian Anomalies: Research Approaches and Clinical Significance.Clin Genet2026https://conductscience.org/library/papers/41556511PubMed
41373741Integrating Bioprinting and Increased Throughput: Next-Generation Models for Cardiac Research.Int J Mol Sci2025https://conductscience.org/library/papers/41373741PubMed
41261979In vitro approaches to mimic cardiac mechanical load dynamics for enhancing maturation and disease modelling.Cardiovasc Res2025https://conductscience.org/library/papers/41261979PubMed
40721504circSP199a, a circularized RNA sponge targeting miR-199a-5p and -3p, mitigates mouse cardiac hypertrophy and fibrosis.Acta Pharmacol Sin2026https://conductscience.org/library/papers/40721504PubMed
40321594Organoid-Guided Precision Medicine: From Bench to Bedside.MedComm (2020)2025https://conductscience.org/library/papers/40321594PubMed
39872935Model construction and clinical therapeutic potential of engineered cardiac organoids for cardiovascular diseases.Biomater Transl2024https://conductscience.org/library/papers/39872935PubMed
39802826Revolutionizing cardiovascular research: Human organoids as a Beacon of hope for understanding and treating cardiovascular diseases.Mater Today Bio2025https://conductscience.org/library/papers/39802826PubMed
39707562Small extracellular vesicles derived from umbilical cord mesenchymal stem cells alleviate radiation-induced cardiac organoid injury.Stem Cell Res Ther2024https://conductscience.org/library/papers/39707562PubMed
39126669Progress in the Application of Organoids-On-A-Chip in Diseases.Organogenesis2024https://conductscience.org/library/papers/39126669PubMed
38543122Differentiation of Pluripotent Stem Cells for Disease Modeling: Learning from Heart Development.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/38543122PubMed
38334642Advances in the Generation of Constructed Cardiac Tissue Derived from Induced Pluripotent Stem Cells for Disease Modeling and Therapeutic Discovery.Cells2024https://conductscience.org/library/papers/38334642PubMed
38110859The benign nature and rare occurrence of cardiac myxoma as a possible consequence of the limited cardiac proliferative/ regenerative potential: a systematic review.BMC Cancer2023https://conductscience.org/library/papers/38110859PubMed
37958655A Strainer-Based Platform for the Collection and Immunolabeling of Porcine Epidemic Diarrhea Virus-Infected Porcine Intestinal Organoid.Int J Mol Sci2023https://conductscience.org/library/papers/37958655PubMed

See all 24 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35525908

GET https://conductscience.org/api/papers/v1/35525908/references?page=2